In addition, ER interacts with EGF receptor and activate tyrosine kinase signaling in breast cancer (15), and EGF, but not IGF or VEGF, promotes H1395 cell proliferation (Supplemental Figure 3A). The gene discussed is IGF1; the disease is breast carcinoma.